XML 16 R5.htm IDEA: XBRL DOCUMENT v3.26.3
Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Deficit - USD ($)
Class A
Common Stock
Class B
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2024 $ 753 $ 6 $ 964,335 $ (6,254,602) $ (5,289,508)
Balance (in Shares) at Dec. 31, 2024 7,528,761 57,752      
Net loss (1,482,444) (1,482,444)
Balance at Mar. 31, 2025 $ 753 $ 6 964,335 (7,737,046) (6,771,952)
Balance (in Shares) at Mar. 31, 2025 7,528,761 57,752      
Balance at Dec. 31, 2024 $ 753 $ 6 964,335 (6,254,602) (5,289,508)
Balance (in Shares) at Dec. 31, 2024 7,528,761 57,752      
Net loss         (4,635,399)
Balance at Sep. 30, 2025 $ 813 $ 6 1,313,605 (10,890,001) (9,575,577)
Balance (in Shares) at Sep. 30, 2025 8,131,081 57,752      
Balance at Mar. 31, 2025 $ 753 $ 6 964,335 (7,737,046) (6,771,952)
Balance (in Shares) at Mar. 31, 2025 7,528,761 57,752      
Net loss (952,771) (952,771)
Balance at Jun. 30, 2025 $ 753 $ 6 964,335 (8,689,817) (7,724,723)
Balance (in Shares) at Jun. 30, 2025 7,528,761 57,752      
Issuance of restricted stock awards to management $ 60 349,270 349,330
Issuance of restricted stock awards to management (in shares) 602,320      
Net loss (2,200,184) (2,200,184)
Balance at Sep. 30, 2025 $ 813 $ 6 1,313,605 (10,890,001) (9,575,577)
Balance (in Shares) at Sep. 30, 2025 8,131,081 57,752      
Balance at Dec. 31, 2025 $ 813 $ 6 2,599,139 (15,345,956) (12,745,998)
Balance (in Shares) at Dec. 31, 2025 8,131,081 57,752      
Stock-based compensation expense 258,143 258,143
Net loss (1,860,228) (1,860,228)
Balance at Mar. 31, 2026 $ 813 $ 6 2,857,282 (17,206,184) (14,348,083)
Balance (in Shares) at Mar. 31, 2026 8,131,081 57,752      
Balance at Dec. 31, 2025 $ 813 $ 6 2,599,139 (15,345,956) (12,745,998)
Balance (in Shares) at Dec. 31, 2025 8,131,081 57,752      
Net loss         (7,714,722)
Balance at Sep. 30, 2026 $ 1,173 $ 6 10,515,736 (23,060,678) (12,543,763)
Balance (in Shares) at Sep. 30, 2026 11,734,135 57,752      
Balance at Mar. 31, 2026 $ 813 $ 6 2,857,282 (17,206,184) (14,348,083)
Balance (in Shares) at Mar. 31, 2026 8,131,081 57,752      
Issuance of equity awards $ 54 1,187,946 1,188,000
Issuance of equity awards (in shares) 540,000      
Conversion of loan to Class A common stock $ 161 3,999,839 4,000,000
Conversion of loan to Class A common stock (in shares) 1,612,903      
Stock-based compensation expense 249,656 249,656
Net loss (3,246,657) (3,246,657)
Balance at Jun. 30, 2026 $ 1,028 $ 6 8,294,723 (20,452,841) (12,157,084)
Balance (in Shares) at Jun. 30, 2026 10,283,984 57,752      
Issuance of Class A common stock under at-the-market offering program, net of allocated offering costs $ 145 1,968,612 1,968,757
Issuance of Class A common stock under at-the-market offering program, net of allocated offering costs (in shares) 1,450,151      
Stock-based compensation expense 252,401 252,401
Net loss (2,607,837) (2,607,837)
Balance at Sep. 30, 2026 $ 1,173 $ 6 $ 10,515,736 $ (23,060,678) $ (12,543,763)
Balance (in Shares) at Sep. 30, 2026 11,734,135 57,752